Fluorouracil

interleukin 1 alpha ; Homo sapiens







21 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35448938 Three important short-chain fatty acids (SCFAs) attenuate the inflammatory response induced by 5-FU and maintain the integrity of intestinal mucosal tight junction. 2022 Apr 21 1
2 35634282 Comprehensive Testing of Chemotherapy and Immune Checkpoint Blockade in Preclinical Cancer Models Identifies Additive Combinations. 2022 2
3 34452150 Cellulose Nanofiber-Based Hydrogels Embedding 5-FU Promote Pyroptosis Activation in Breast Cancer Cells and Support Human Adipose-Derived Stem Cell Proliferation, Opening New Perspectives for Breast Tissue Engineering. 2021 Aug 1 1
4 30583087 Exogenous interleukin-1α signaling negatively impacts acquired chemoresistance and alters cell adhesion molecule expression pattern in colorectal carcinoma cells HCT116. 2019 Feb 2
5 31120863 PI3 kinase alpha and delta promote hematopoietic stem cell activation. 2019 May 23 1
6 15001844 Synthesis and biological activities in vitro and in vivo of glycosylated human interleukin-1alpha, neoglyco IL-1alpha, coupled with N -acetylneuraminyl-galactose. 2004 1
7 9143391 Phase I trial of subcutaneous interleukin-1 alpha in children with malignant solid tumors. 1997 Jun 2
8 9238541 Effect of 5-fluorouracil on interleukin-1 and interleukin-2 receptor expression. 1997 Jun 4
9 9262988 Cytokine-mediated expansion does not deplete cord blood cells with stem cell characteristics. 1997 Jun 1
10 7534710 Cytokine-mediated expansion of 5-FU-resistant peripheral blood stem cells. 1995 Apr 2
11 7522897 Cytokine-mediated expansion of 5-FU resistant peripheral blood stem cells and bone marrow: self-renewal and commitment capacity. 1994 Summer 1
12 7787251 Enhanced cytotoxicity with interleukin-1 alpha and 5-fluorouracil in HCT116 colon cancer cells. 1994 2
13 8142915 Stem cell responses in myelosuppressed mice following sequential treatment with recombinant human interleukin 1 (rHuIL-1), recombinant murine interleukin 3 (rMuIL-3) and recombinant human macrophage colony-stimulating factor (rHuM-CSF). 1994 Jan 2
14 8339382 Cytokines induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5'-deoxy-5-fluorouridine. 1993 4
15 1587305 Synergy between recombinant human IL-1 alpha (rHuIL-1) and M-CSF (rHuM-CSF) during the recovery of murine hematopoietic activity in myelosuppressed animals: abbreviated versus chronic administration of rHuM-CSF. 1992 Jun 6
16 1638519 Prevention of acute chemotherapy-induced death in mice by recombinant human interleukin 1: protection from hematological and nonhematological toxicities. 1992 Aug 1 2
17 2060021 Accelerated recovery of antigen-presenting cell activity by the administration of interleukin 1 alpha in 5-fluorouracil-treated mice. 1991 Aug 2
18 2258610 Chemoprotective effects of recombinant human IL-1 alpha in cyclophosphamide-treated normal and tumor-bearing mice. Protection from acute toxicity, hematologic effects, development of late mortality, and enhanced therapeutic efficacy. 1990 Dec 15 1
19 2685478 In vivo effects of interleukin-1 alpha on regenerating mouse bone marrow myeloid colony-forming cells after treatment with 5-fluorouracil. 1989 Dec 1
20 3264195 Synergistic factors for stem cell proliferation: further studies of the target stem cells and the mechanism of stimulation by interleukin-1, interleukin-6, and granulocyte colony-stimulating factor. 1988 Dec 3
21 3499607 Synergy of interleukin 1 and granulocyte colony-stimulating factor: in vivo stimulation of stem-cell recovery and hematopoietic regeneration following 5-fluorouracil treatment of mice. 1987 Oct 2